相似文献
1
Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.
CMAJ. 2003 Apr 1;168(7):872-3.
2
Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
Lancet. 2003 Aug 9;362(9382):495. doi: 10.1016/S0140-6736(03)14084-6.
3
Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.
Emerg Infect Dis. 2012 Aug;18(8):1290-7. doi: 10.3201/eid1808.111202.
4
Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
Sex Transm Dis. 2002 Dec;29(12):780-8. doi: 10.1097/00007435-200212000-00008.
5
The rise and fall of ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Int J STD AIDS. 2005 Jan;16(1):83. doi: 10.1258/0956462052932791.
6
[Gonococcus: the disturbing development of strains resistant to ciprofloxacin].
Rev Med Suisse. 2006 Jan 18;2(49):250.
7
RE: Ciprofloxacin resistance in Great Yarmouth and Waveney district.
J Eur Acad Dermatol Venereol. 2006 Feb;20(2):216-7. doi: 10.1111/j.1468-3083.2005.01361.x.
8
Increase of Neisseria gonorrhoeae ciprofloxacin resistance in France in 2001-2003.
Sex Transm Dis. 2006 Jan;33(1):6-7. doi: 10.1097/01.olq.0000187197.85419.f8.
9
Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.
Sex Transm Dis. 2011 Oct;38(10):892-8. doi: 10.1097/OLQ.0b013e31822c664f.
10
Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995.
Can Commun Dis Rep. 1996 Aug 1;22(15):121-4; discussion 124-5.
引用本文的文献
1
Antimicrobial susceptibility profile of Gonococcal isolates obtained from men presenting with urethral discharge in Addis Ababa, Ethiopia: Implications for national syndromic treatment guideline.
PLoS One. 2020 Jun 1;15(6):e0233753. doi: 10.1371/journal.pone.0233753. eCollection 2020.
2
Pilus phase variation switches gonococcal adherence to invasion by caveolin-1-dependent host cell signaling.
PLoS Pathog. 2013;9(5):e1003373. doi: 10.1371/journal.ppat.1003373. Epub 2013 May 23.
3
The laboratory diagnosis of Neisseria gonorrhoeae.
Can J Infect Dis Med Microbiol. 2005 Jan;16(1):15-25. doi: 10.1155/2005/323082.
4
Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.
Emerg Infect Dis. 2005 Aug;11(8):1265-73. doi: 10.3201/eid1108.050157.
5
Drug-resistant Neisseria gonorrhoeae in Michigan.
Emerg Infect Dis. 2005 Jul;11(7):1009-15. doi: 10.3201/eid1107.041359.
6
Gonorrhea treatment guidelines in Canada: 2004 update.
CMAJ. 2004 Nov 23;171(11):1345-6. doi: 10.1503/cmaj.045088.
本文引用的文献
1
Gonorrhoea resurgence in Canada.
Int J STD AIDS. 2003 Nov;14(11):727-31. doi: 10.1258/09564620360719741.
2
Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
MMWR Morb Mortal Wkly Rep. 2002 Nov 22;51(46):1041-4.
3
Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
MMWR Morb Mortal Wkly Rep. 2000 Sep 22;49(37):833-7.
4
The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi.
Lancet. 1998;351 Suppl 3:8-11. doi: 10.1016/s0140-6736(98)90003-4.
5
Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
MMWR Morb Mortal Wkly Rep. 1998 May 29;47(20):405-8.
6
Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995.
Can Commun Dis Rep. 1996 Aug 1;22(15):121-4; discussion 124-5.
7
Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ontario, 1992-1994.
Can Commun Dis Rep. 1995 Feb 15;21(3):17-20; discussion 20-1.
8
Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon.
Can Commun Dis Rep. 1995 Aug 15;21(15):137-9.
Zotero 插件